The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma

Journal of Neuro-Oncology

Volumn 62, Issue 1-2, 2003, Pages 187-195

  Kabalka, George W ^a   Nichols, Trent L ^a   Smith, Gary T ^a   Miller, Laurence F ^b   Khan, Mohammad K ^b   Busse, Paul M ^c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b University of Tennessee Knoxville   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

BNCT; Melanoma; Para boronophenylalanine; PET

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BORON 10; BORONOPHENYLALANINE F 18; CISPLATIN; DACARBAZINE; DEXAMETHASONE; IMMUNOMODULATING AGENT; INTERLEUKIN 2; PREDNISONE; RADIOPHARMACEUTICAL AGENT; STEROID; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; AUTOPSY; BRAIN EDEMA; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DESQUAMATION; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; ERYTHEMA; HEAD; HUMAN; HUNGER; KIDNEY FAILURE; LUNG METASTASIS; MALE; MELANOMA; MUSCLE WEAKNESS; NEUTRON CAPTURE THERAPY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRURITUS; RESPIRATORY FAILURE; SIDE EFFECT; THORAX; TREATMENT PLANNING;

BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN; BRAIN NEOPLASMS; FLUORINE RADIOISOTOPES; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0038707483     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023236921638     Document Type: Article

References (25)

1. Armstrong BK: Epidemiology of malignant melanoma: Intermittant or total accumulated exposure to the sun. J Dermatol Surg Oncol 14: 835, 1988
2. Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Faucin AS, Root RK: Harrison's principles of internal medicine. In: Wilson JD (ed) Harrison's Principles of Internal Medicine. 12th edn., Vol 2, McGraw-Hill, New York, p 2016, 1991
3. Hawthorne MF: New horizons for therapy based on the boron neutron capture reaction. Mol Med Today 4: 174-181, 1998
4. Hiratsuka J, Fukuda H, Kobayashi T, Kanda K, Honda C, Ichihashi M, Mishima Y: Human melanoma treated by boron neutron capture therapy: Comparison of the clinical response with the predicted response. Radiat Med 14: 257-263, 1996
5. 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat Res 138: 435-442, 1994
6. Pignol JP, Abbe JC, Lefebvre O, Stampfler A, Methlin G, Shel J: Therapy by neutron capture of ocular melanoma: Dosimetry and microdosimetry. CR Acad Sci III 317: 543-548, 1994
7. Barth RF, Soloway AH: Boron neutron capture therapy of primary and metastatic brain tumors. Mol Chem Neuropathol 21: 139-154, 1994
8. Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R: Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part I. Clin Cancer Res 4: 1825-1832, 1998
9. Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R: Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part II. Clin Cancer Res 4: 1833-1841, 1998
10. Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R, Ido T: Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 39: 325-333, 1998
11. Imahori Y, Ueda S, Ohmori Y, et al.: A Basic Concept for a PET-BNCT System. In: Mishima Y (ed), Plenum Press, Kobe, Japan, pp 691-696, 1994
12. Ishiwata K, Ido T, Honda C, Kawamura M, Ichihashi M, Mishima Y: 4-Borono-2-[18F]fluoro-D,L-phenylalanine: A possible tracer for melanoma diagnosis with PET. Int J Radiat Appl Instrum B 19: 311-318, 1992
13. Ishiwata K, Ido T, Kawamura M, Kubota K, Ichihashi M, Mishima Y: 4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: Tumor imaging potential with positron emission tomography. Int J Radiat Appl Instrum B 18: 745-751, 1991
14. Ishiwata K, Ido T, Kawamura M, Kubota K, Ichihashi M, Mishima Y: 4-boron-2-[F-18]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: Tumor imaging potential with positron emission tomography. Int J Radiat Appl Instrum. Nucl Med Biol 18(Part B): 745-751, 1991
15. Ishiwata K, Shiono M, Kubota K: A unique in vivo assessment of 4-[B-10]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy malignant melanomas using positron emission tomography 4-borono-2-[F-18]fluoro-L-phenylalanine. Melanoma Res 2: 171-174, 1992
16. Ishiwata K, Shiono M, Kubota K, Yoshino K, Hatazawa J, Ido T, Honda C, Ichihashi M, Mishima Y: A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine. Melanoma Res 2: 171-179, 1992
17. Kabalka GW, Hübner KF, Smith GT, Reid WS, Longford CPD, Roberts TG, Reddy NK, Srivastava R, Narayana C: Synthesis and preliminary evaluation of boronated agents labeled with positron emitting isotopes for use in boron neutron capture therapy treatment planning. In: Larsson B, Crawford J, Weinrich R (eds) Advances in Neutron Capture Therapy. Vol. 2, Elsevier, New York, pp 276-279, 1997
18. Chandra S, Kabalka GW, Lorey DR, Smith DR, Coderre JA. Imaging of fluorine and boron from fluorinated-boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy. Clin Cancer Res 8: 2675-2683, 2002
19. Nigg DW: Methods for radiation dose distribution analysis and treatment planning in boron neutron capture therapy. Int J Radiat Oncol Biol Phys 28(5): 1121-1134, 1994
20. Nigg DW, Wheeler FJ, Wessol DE, Capala J, Chadha M: Computational dosimetry and treatment planning for boron neutron capture therapy. J Neuro-Oncol 33: 93-104, 1997
21. Nigg DW, Wheeler FJ, Wessol DE, Capala J, Chadha M. Computational dosimetry and treatment planning for boron neutron capture therapy. J Neuro-Oncol 1997; 33(1-2): 93-104, 1997
22. Busse P: Brain Autopsy on Patient with Intracranial Metastatic Melanoma, 1998
23. Johnson LS, Yanch JC: Absorbed dose profiles for radionuclides of frequent use in radiation synovectomy. Arth Rheum 34: 1521-1530, 1991
24. Johnson LS, Yanch JC: Calculation of beta dosimetry in radiation synovectomy using Monte Carlo simulation (EGS4). Med Phys 20: 747-754, 1993
25. Gierga DP, Yanch JC, Shefer RE: Development and construction of a neutron beam line for accelerator-based boron neutron capture synovectomy. Med Phys 27: 203-214, 2000